Shopping Cart 0
Cart Subtotal
USD 0

Northwestern University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Northwestern University is an educational service provider that offers graduate professional and undergraduate educational programs. The university offers graduate and professional programs which include communication, education and social policy, engineering and applied sciences, journalism, media, integrated marketing communications, law, management, medicine and music. Northwestern University offers undergraduate programs such as anthropology, Asian languages and cultures, biological sciences, biotechnology and biochemical engineering, civil engineering, communication studies, computer engineering, economics and industrial engineering. The university also conducts pre-collegiate programs. It also operates campuses in Chicago. Northwestern University is headquartered in Evanston, Illinois, the US.

Northwestern University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Northwestern University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Northwestern University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Northwestern University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Northwestern University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Northwestern University, Medical Devices Deals, 2012 to YTD 2018 10

Northwestern University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Northwestern University, Pharmaceuticals & Healthcare, Deal Details 14

Venture Financing 14

Aptinyx Raises USD70 Million in Series B Financing 14

Aptinyx Raises USD65 Million in Series A Venture Financing 16

Naurex Raises USD80 Million in Series C Venture Financing 18

Naurex Raises USD 38 Million In Series B Financing 20

Partnerships 22

Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 22

Context Therapeutics Enters into Research Collaborations for Apristor 23

Galderma Enters into Research Agreement with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine 25

AbbVie Enters into Research Agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern University 26

Solid Biosciences Enters into Co-Development Agreement with Northwestern University 27

BioAegis Therapeutics Enters into Agreement with Vanderbilt University and Northwestern University 28

Evestra Enters into Research Agreement with Northwestern University 29

Immunovative Therapies To Enter Into Co-Development Agreement With Robert H. Lurie Comprehensive Cancer Center 30

Licensing Agreements 32

Ovid Therapeutics Enters into Licensing Agreement with Northwestern University 32

Exicure Enters into Licensing Agreement with Northwestern University 34

Exicure Enters into Licensing Agreement with Northwestern University for SNA Technology 35

Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 36

Intellect Neurosciences Enters into License Agreement with Northwestern University 37

Northwestern University-Key Competitors 38

Northwestern University-Key Employees 39

Northwestern University-Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Recent Developments 42

Government and Public Interest 42

Aug 30, 2018: Online HIV prevention program receives USD 8.8 million NIH grant 42

Aug 28, 2018: Cancer patients guaranteed oncofertility treatment coverage under new Illinois Law 43

Aug 20, 2018: USD 11.5 Million NCI Award to Accelerate Brain Tumor Research 45

Aug 09, 2018: Discovery could lead to better treatment for leukemia 46

Aug 07, 2018: Prompt treatment improves outcomes in pediatric sepsis 48

Jul 31, 2018: Scientists identify new therapeutic target in diabetes 49

Jul 26, 2018: Rethinking longstanding treatment for diabetes complications 50

Jul 18, 2018: St. Baldrick's foundation announces USD 19.1 million in grants to fund lifesaving childhood cancer research 51

Jul 12, 2018: Bioengineers create pathway to personalized medicine 52

Jun 29, 2018: Northwestern Medicine Receives Grant to Lead Research into Atrial Fibrillation and Stroke 54

Jun 26, 2018: Northwestern Medicine Receives Transformative USD 25 Million Gift from the Bluhm Family Charitable Foundation 55

Jun 25, 2018: Drug Protects Neurons in Parkinson's Disease 57

Jun 12, 2018: More than USD 28 million awarded for new atrial fibrillation research centers to improve patient outcomes 59

Jun 04, 2018: New nanoparticles help to detect serious scarring of wounds 60

May 24, 2018: Northwestern receives USD 10 million to establish quantitative biology research center 62

Apr 26, 2018: Molecule May be Key to Pain Relief in Diabetic Neuropathy 64

Apr 16, 2018: Top-down approach gets to the bottom of cancer 65

Mar 19, 2018: Rheumatoid arthritis meets precision medicine 67

Mar 13, 2018: Scientists Discover Novel Treatment Target for Sepsis 68

Feb 14, 2018: Global Team Wins USD 15 Million To Help End Preventable Newborn Deaths in Africa 69

Feb 13, 2018: New Machine Learning Algorithm Uncovers Time-Delayed Interactions in Gene Regulatory Systems 70

Feb 12, 2018: Molecule Found in Huntington's Patients Kills Cancer Cells 71

Dec 20, 2017: Scientists Reprogram Stem Cells to Regenerate Muscle in Muscular Dystrophy 73

Dec 18, 2017: New Findings Point to Potential Therapy for Parkinson's Disease 74

Nov 08, 2017: Nanoshells could deliver more chemo with fewer side effects 76

Nov 01, 2017: Northwestern University Researcher Congcong he Receives USD 100,000 2017 New Investigator Award in Alzhemiers Disease 78

Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 79

Oct 27, 2017: Johns Hopkins Partnering with Other Institutions to Create a National Center for Health Data 82

Oct 17, 2017: Wasabi receptor' for pain discovered in flatworms 83

Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 85

Jul 12, 2017: Nanomedicine opens door to precision medicine for brain tumors 86

Jul 10, 2017: New technology to manipulate cells could one day help treat Parkinson's, arthritis, other diseases 87

Jun 20, 2017: New Cancer Drug Can Prevent Reactions to Common Airborne Allergens AddThis Sharing Buttons Share to Pinterest 89

Apr 10, 2017: Scientists Develop Novel Platform to Investigate Therapeutic Nanomaterials 90

Feb 02, 2017: Insights Into Enzyme Targets Could Lead to New Cancer Therapies 92

Jan 10, 2017: Engineering Nanomaterials to Deliver Precise Treatments for Heart Disease 93

Product News 94

Jun 22, 2018: Research team discovers drug compound that stops cancer cells from spreading 94

May 24, 2017: Cold virus, stem cells tested to destroy deadly brain cancer 96

May 07, 2018: New Biotech Technique Accelerates Protein Therapy Research 97

Apr 11, 2018: New Methodology Helps Study of Promising Targeted Drug Delivery Scaffold 99

Mar 26, 2018: Scientists Develop New Tool to Study Nicotine Receptors 101

Jan 19, 2017: Northwestern University: Clinical Trials Evaluate New Treatment for Anal Cancer 102

Other Significant Developments 103

Jun 26, 2018: Northwestern University: Fighting Cancer With A Famous Poison 103

Appendix 105

Methodology 105

About GlobalData 105

Contact Us 105

Disclaimer 105


List Of Figure

List of Figures

Northwestern University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Northwestern University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Northwestern University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Northwestern University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Northwestern University, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Northwestern University, Pharmaceuticals & Healthcare, Key Facts 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Northwestern University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Northwestern University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Northwestern University, Deals By Therapy Area, 2012 to YTD 2018 9

Northwestern University, Medical Devices Deals, 2012 to YTD 2018 10

Northwestern University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Aptinyx Raises USD70 Million in Series B Financing 14

Aptinyx Raises USD65 Million in Series A Venture Financing 16

Naurex Raises USD80 Million in Series C Venture Financing 18

Naurex Raises USD 38 Million In Series B Financing 20

Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 22

Context Therapeutics Enters into Research Collaborations for Apristor 23

Galderma Enters into Research Agreement with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine 25

AbbVie Enters into Research Agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern University 26

Solid Biosciences Enters into Co-Development Agreement with Northwestern University 27

BioAegis Therapeutics Enters into Agreement with Vanderbilt University and Northwestern University 28

Evestra Enters into Research Agreement with Northwestern University 29

Immunovative Therapies To Enter Into Co-Development Agreement With Robert H. Lurie Comprehensive Cancer Center 30

Ovid Therapeutics Enters into Licensing Agreement with Northwestern University 32

Exicure Enters into Licensing Agreement with Northwestern University 34

Exicure Enters into Licensing Agreement with Northwestern University for SNA Technology 35

Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 36

Intellect Neurosciences Enters into License Agreement with Northwestern University 37

Northwestern University, Key Competitors 38

Northwestern University, Key Employees 39

Northwestern University, Other Locations 40

Northwestern University, Subsidiaries 41

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Northwestern University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Northwestern University is an educational service provider that offers graduate professional and undergraduate educational programs. The university offers graduate and professional programs which include communication, education and social policy, engineering and applied sciences, journalism, media, integrated marketing communications, law, management, medicine and music. Northwestern University offers undergraduate programs such as anthropology, Asian languages and cultures, biological sciences, biotechnology and biochemical engineering, civil engineering, communication studies, computer engineering, economics and industrial engineering. The university also conducts pre-collegiate programs. It also operates campuses in Chicago. Northwestern University is headquartered in Evanston, Illinois, the US.

Northwestern University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Northwestern University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Northwestern University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Northwestern University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Northwestern University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Northwestern University, Medical Devices Deals, 2012 to YTD 2018 10

Northwestern University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Northwestern University, Pharmaceuticals & Healthcare, Deal Details 14

Venture Financing 14

Aptinyx Raises USD70 Million in Series B Financing 14

Aptinyx Raises USD65 Million in Series A Venture Financing 16

Naurex Raises USD80 Million in Series C Venture Financing 18

Naurex Raises USD 38 Million In Series B Financing 20

Partnerships 22

Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 22

Context Therapeutics Enters into Research Collaborations for Apristor 23

Galderma Enters into Research Agreement with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine 25

AbbVie Enters into Research Agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern University 26

Solid Biosciences Enters into Co-Development Agreement with Northwestern University 27

BioAegis Therapeutics Enters into Agreement with Vanderbilt University and Northwestern University 28

Evestra Enters into Research Agreement with Northwestern University 29

Immunovative Therapies To Enter Into Co-Development Agreement With Robert H. Lurie Comprehensive Cancer Center 30

Licensing Agreements 32

Ovid Therapeutics Enters into Licensing Agreement with Northwestern University 32

Exicure Enters into Licensing Agreement with Northwestern University 34

Exicure Enters into Licensing Agreement with Northwestern University for SNA Technology 35

Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 36

Intellect Neurosciences Enters into License Agreement with Northwestern University 37

Northwestern University-Key Competitors 38

Northwestern University-Key Employees 39

Northwestern University-Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Recent Developments 42

Government and Public Interest 42

Aug 30, 2018: Online HIV prevention program receives USD 8.8 million NIH grant 42

Aug 28, 2018: Cancer patients guaranteed oncofertility treatment coverage under new Illinois Law 43

Aug 20, 2018: USD 11.5 Million NCI Award to Accelerate Brain Tumor Research 45

Aug 09, 2018: Discovery could lead to better treatment for leukemia 46

Aug 07, 2018: Prompt treatment improves outcomes in pediatric sepsis 48

Jul 31, 2018: Scientists identify new therapeutic target in diabetes 49

Jul 26, 2018: Rethinking longstanding treatment for diabetes complications 50

Jul 18, 2018: St. Baldrick's foundation announces USD 19.1 million in grants to fund lifesaving childhood cancer research 51

Jul 12, 2018: Bioengineers create pathway to personalized medicine 52

Jun 29, 2018: Northwestern Medicine Receives Grant to Lead Research into Atrial Fibrillation and Stroke 54

Jun 26, 2018: Northwestern Medicine Receives Transformative USD 25 Million Gift from the Bluhm Family Charitable Foundation 55

Jun 25, 2018: Drug Protects Neurons in Parkinson's Disease 57

Jun 12, 2018: More than USD 28 million awarded for new atrial fibrillation research centers to improve patient outcomes 59

Jun 04, 2018: New nanoparticles help to detect serious scarring of wounds 60

May 24, 2018: Northwestern receives USD 10 million to establish quantitative biology research center 62

Apr 26, 2018: Molecule May be Key to Pain Relief in Diabetic Neuropathy 64

Apr 16, 2018: Top-down approach gets to the bottom of cancer 65

Mar 19, 2018: Rheumatoid arthritis meets precision medicine 67

Mar 13, 2018: Scientists Discover Novel Treatment Target for Sepsis 68

Feb 14, 2018: Global Team Wins USD 15 Million To Help End Preventable Newborn Deaths in Africa 69

Feb 13, 2018: New Machine Learning Algorithm Uncovers Time-Delayed Interactions in Gene Regulatory Systems 70

Feb 12, 2018: Molecule Found in Huntington's Patients Kills Cancer Cells 71

Dec 20, 2017: Scientists Reprogram Stem Cells to Regenerate Muscle in Muscular Dystrophy 73

Dec 18, 2017: New Findings Point to Potential Therapy for Parkinson's Disease 74

Nov 08, 2017: Nanoshells could deliver more chemo with fewer side effects 76

Nov 01, 2017: Northwestern University Researcher Congcong he Receives USD 100,000 2017 New Investigator Award in Alzhemiers Disease 78

Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 79

Oct 27, 2017: Johns Hopkins Partnering with Other Institutions to Create a National Center for Health Data 82

Oct 17, 2017: Wasabi receptor' for pain discovered in flatworms 83

Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 85

Jul 12, 2017: Nanomedicine opens door to precision medicine for brain tumors 86

Jul 10, 2017: New technology to manipulate cells could one day help treat Parkinson's, arthritis, other diseases 87

Jun 20, 2017: New Cancer Drug Can Prevent Reactions to Common Airborne Allergens AddThis Sharing Buttons Share to Pinterest 89

Apr 10, 2017: Scientists Develop Novel Platform to Investigate Therapeutic Nanomaterials 90

Feb 02, 2017: Insights Into Enzyme Targets Could Lead to New Cancer Therapies 92

Jan 10, 2017: Engineering Nanomaterials to Deliver Precise Treatments for Heart Disease 93

Product News 94

Jun 22, 2018: Research team discovers drug compound that stops cancer cells from spreading 94

May 24, 2017: Cold virus, stem cells tested to destroy deadly brain cancer 96

May 07, 2018: New Biotech Technique Accelerates Protein Therapy Research 97

Apr 11, 2018: New Methodology Helps Study of Promising Targeted Drug Delivery Scaffold 99

Mar 26, 2018: Scientists Develop New Tool to Study Nicotine Receptors 101

Jan 19, 2017: Northwestern University: Clinical Trials Evaluate New Treatment for Anal Cancer 102

Other Significant Developments 103

Jun 26, 2018: Northwestern University: Fighting Cancer With A Famous Poison 103

Appendix 105

Methodology 105

About GlobalData 105

Contact Us 105

Disclaimer 105


List Of Figure

List of Figures

Northwestern University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Northwestern University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Northwestern University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Northwestern University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Northwestern University, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Northwestern University, Pharmaceuticals & Healthcare, Key Facts 2

Northwestern University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Northwestern University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Northwestern University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Northwestern University, Deals By Therapy Area, 2012 to YTD 2018 9

Northwestern University, Medical Devices Deals, 2012 to YTD 2018 10

Northwestern University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Aptinyx Raises USD70 Million in Series B Financing 14

Aptinyx Raises USD65 Million in Series A Venture Financing 16

Naurex Raises USD80 Million in Series C Venture Financing 18

Naurex Raises USD 38 Million In Series B Financing 20

Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 22

Context Therapeutics Enters into Research Collaborations for Apristor 23

Galderma Enters into Research Agreement with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine 25

AbbVie Enters into Research Agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern University 26

Solid Biosciences Enters into Co-Development Agreement with Northwestern University 27

BioAegis Therapeutics Enters into Agreement with Vanderbilt University and Northwestern University 28

Evestra Enters into Research Agreement with Northwestern University 29

Immunovative Therapies To Enter Into Co-Development Agreement With Robert H. Lurie Comprehensive Cancer Center 30

Ovid Therapeutics Enters into Licensing Agreement with Northwestern University 32

Exicure Enters into Licensing Agreement with Northwestern University 34

Exicure Enters into Licensing Agreement with Northwestern University for SNA Technology 35

Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 36

Intellect Neurosciences Enters into License Agreement with Northwestern University 37

Northwestern University, Key Competitors 38

Northwestern University, Key Employees 39

Northwestern University, Other Locations 40

Northwestern University, Subsidiaries 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Northwestern University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.